Search
Now showing items 1-10 of 17
Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease
(Elsevier, 2019-08-11)
[Abstract]
Introduction: There is little control of cardiovascular (CV) risk factors in secondary prevention after an ischaemic stroke, in part due to a lack of adherence to treatment. The CV polypill may contribute ...
RP11-362K2.2:RP11-767I20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma: a GWAS meta-analysis
(MDPI, 2021-07-16)
[Abstract] Stroke is one of the most common causes of death and disability. Reperfusion therapies are the only treatment available during the acute phase of stroke. Due to recent clinical trials, these therapies may increase ...
Stroke prevention in patients with arterial hypertension: recommendations of the Spanish Society of Neurology's Stroke Study Group
(Elsevier, 2021-04-23)
[Abstract]
Objective: To update the recommendations of the Spanish Society of Neurology on primary and secondary stroke prevention in patients with arterial hypertension.
Development: We proposed several questions ...
A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment
(Elsevier, 2023-12-15)
[Abstract]
Background: Thrombolytic recombinant tissue plasminogen activator (r-tPA) treatment is the only pharmacologic intervention available in the ischemic stroke acute phase. This treatment is associated with an ...
Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: consensus document and practice guidance
(Elsevier, 2021-12-11)
[Abstract]
Introduction: Patients with history of stroke or transient ischaemic attack present considerable risk of future vascular events. Reducing levels of low-density lipoprotein (LDL) cholesterol decreases the ...
Recommendations of the Spanish Society of Neurology for the prevention of stroke: interventions on lifestyle and air pollution
(Elsevier, 2021-03-27)
[Abstract]
Objective: To update the recommendations of the Spanish Society of Neurology regarding lifestyle interventions for stroke prevention.
Development: We reviewed the most recent studies related to lifestyle ...
Impact of COVID-19 outbreak on ischemic stroke admissions and in-hospital mortality in North-West Spain
(Sage, 2020-06-11)
[Abstract]
Background and purpose: Spain has been one of the countries heavily stricken by COVID-19. But this epidemic has not affected all regions equally. We analyzed the impact of the COVID-19 pandemic on hospital ...
Safety and efficacy of ApTOLL in patients with ischemic stroke undergoing endovascular treatment: a phase 1/2 randomized clinical trial
(American Medical Association, 2023-06-20)
[Abstract] Importance: ApTOLL is a TLR4 antagonist with proven preclinical neuroprotective effect and a safe profile in healthy volunteers.
Objective: To assess the safety and efficacy of ApTOLL in combination with ...
Prevención de ictus en pacientes con diabetes mellitus tipo 2 o prediabetes: recomendaciones del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología
(Elsevier, 2020-09-24)
[Resumen] Objetivo. Actualizar las recomendaciones de la Sociedad Española de Neurología para la prevención del ictus en pacientes con DM-2 o prediabetes, analizando las evidencias disponibles sobre el efecto del control ...
Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology
(Elsevier, 2022-01)
[Abstract]
Objective: We present an update of the Spanish Society of Neurology's recommendations for prevention of both primary and secondary stroke in patients with dyslipidaemia.
Development: We performed a ...
